Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel S Key

Showing results (41-50 of 255) with videos related to

Pageof 26
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|June 9, 2007
Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosisNigel Mackman, Rachel E Tilley, Nigel S Key
Journal of the American Society of Hypertension : JASH|July 14, 2012
Microparticles in cardiovascular disease pathophysiology and outcomesAnthony J Viera, Micah Mooberry, Nigel S Key
Anesthesiology|August 12, 2010
Novel oral anticoagulants: implications in the perioperative settingJerrold H Levy, Nigel S Key, Marc S Azran
Thrombosis Research|April 25, 2014
Red blood cells and thrombin generation in sickle cell diseaseMatthew F Whelihan, Ming Y Lim, Nigel S Key
Haematologica|March 16, 2019
Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosisVictor R Gordeuk, Nigel S Key, Josef T Prchal
Current Opinion in Anaesthesiology|March 15, 2006
Activated recombinant factor VII in cardiac surgeryMarie E Steiner, Nigel S Key, Jerrold H Levy
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|January 12, 2007
Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometerSílvia Perez-Pujol, Paul H Marker, Nigel S Key
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 23, 2019
How to discuss gene therapy for haemophilia? A patient and physician perspectiveWolfgang Miesbach, Brian O'Mahony, Nigel S Key, et al.
Journal of Thrombosis and Haemostasis : JTH|August 22, 2024
Comparison of thrombotic adverse events in patients treated with factor VIII products and emicizumab using the 2018-2022 US Food and Drug Administration Adverse Event Reporting System data: comment from Berkowitz et alCallie Berkowitz, Samuel Wilson, Nigel S Key, et al.
Case Reports in Hematology|July 30, 2019
Prolonged Remission of Cancer of Unknown Primary following Initiation of Eculizumab Therapy for Paroxysmal Nocturnal HemoglobinuriaMing Y Lim, Keith E Volmar, Nigel S Key
Pageof 26

Showing results (41-50 of 255) with videos related to

Sort By:
Pageof 26
Arteriosclerosis, Thrombosis, and Vascular Biology|June 9, 2007
Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosisNigel Mackman, Rachel E Tilley, Nigel S Key
Journal of the American Society of Hypertension : JASH|July 14, 2012
Microparticles in cardiovascular disease pathophysiology and outcomesAnthony J Viera, Micah Mooberry, Nigel S Key
Anesthesiology|August 12, 2010
Novel oral anticoagulants: implications in the perioperative settingJerrold H Levy, Nigel S Key, Marc S Azran
Thrombosis Research|April 25, 2014
Red blood cells and thrombin generation in sickle cell diseaseMatthew F Whelihan, Ming Y Lim, Nigel S Key
Haematologica|March 16, 2019
Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosisVictor R Gordeuk, Nigel S Key, Josef T Prchal
Current Opinion in Anaesthesiology|March 15, 2006
Activated recombinant factor VII in cardiac surgeryMarie E Steiner, Nigel S Key, Jerrold H Levy
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|January 12, 2007
Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometerSílvia Perez-Pujol, Paul H Marker, Nigel S Key
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 23, 2019
How to discuss gene therapy for haemophilia? A patient and physician perspectiveWolfgang Miesbach, Brian O'Mahony, Nigel S Key, et al.
Journal of Thrombosis and Haemostasis : JTH|August 22, 2024
Comparison of thrombotic adverse events in patients treated with factor VIII products and emicizumab using the 2018-2022 US Food and Drug Administration Adverse Event Reporting System data: comment from Berkowitz et alCallie Berkowitz, Samuel Wilson, Nigel S Key, et al.
Case Reports in Hematology|July 30, 2019
Prolonged Remission of Cancer of Unknown Primary following Initiation of Eculizumab Therapy for Paroxysmal Nocturnal HemoglobinuriaMing Y Lim, Keith E Volmar, Nigel S Key
Pageof 26